ArticleVaccine2014
Does the HPV vaccination programme have implications for cervical screening programmes in the UK?
Article in Vaccine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.
- Association of human papillomavirus vaccination with cervical cancer screening: A systematic review and meta-analysis.Medicine · 2022Pooled it
- Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening.Clinics (Sao Paulo, Brazil) · 2018Pooled it
- Identifying the key barriers, facilitators and factors associated with cervical cancer screening attendance in young women: A systematic review.Women's health (London, England)Pooled it
- The Enablers and Barriers to Accessing Women's Health and Wellbeing Services for Women Aged 40-65 Years: A Qualitative Study.Community health equity research & policy · 2026Article
- Predictive modeling for cervical cancer: existing AI approaches and the emerging role of vaginal microbiome.Frontiers in network physiology · 2026Article
- Utilising the COM-B model to interpret barriers and facilitators to cervical cancer screening in young women.Journal of health psychology · 2025Article
- The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands: a population-based linkage study.The Lancet regional health. Europe · 2025Article
- A transversal cross-sectional study of factors related to HPV vaccination status and cancer screening participation among French women aged 25-40.BMC cancer · 2024Article
- Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.BMJ (Clinical research ed.) · 2024Observational
- Social factors and age play a significant role in cervical cancer and advanced-stage disease among Danish women.BMC cancer · 2024Article
- Cervical cancer screening guidelines and screening practices in 11 countries: A systematic literature review.Preventive medicine reports · 2022Article
- Non-Adherence To Childhood HPV Vaccination Is Associated With Non-Participation In Cervical Cancer ScreeningClinical epidemiology · 2019Article
- Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme.BMC public health · 2018Article
- Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study.BMJ open · 2018Article
- Article
- Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study.The Lancet. Public health · 2018Article
- Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.Journal of women's health (2002) · 2017Article
- Article
- Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.American journal of obstetrics and gynecology · 2017Article
- How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study.BMC public health · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
Abstract
In the UK, a national HPV immunisation programme was implemented in 2008 for girls aged 12-13 years. In addition a catch-up programme was implemented for older girls up to 18 years of age from 2009 to 2011, with an uptake rate of 49.4%. Information about future uptake of cervical screening according to vaccination statistics is important in order to understand the impact of the vaccination programme and implications for a national cervical screening programme. We analysed data on a cohort of women who had been offered the HPV vaccine in the catch-up programme and were invited for cervical screening between 2010 and 2012 in Wales (n=30,882), in a record-linked database study, to describe the cervical screening uptake and clinical outcome according to HPV vaccination status. In our cohort, 48.5% (n=14,966) women had had HPV vaccination and 45.9% (n=14,164) women attended for cervical screening. Women who were unvaccinated were less likely to attend cervical screening (adjusted OR 0.58; 95% CI (0.55, 0.61)). Of those who attended for screening, 13.9% of vaccinated women had abnormal cytology reported compared to 16.7% of women who were unvaccinated. Women who lived in areas with high levels of social deprivation were less likely to be vaccinated (Quintile 5 OR 0.48 95% CI (0.45, 0.52)) or attend cervical screening (Quintile 5 OR 0.70; 95% CI (0.65, 0.75)) compared to those who lived in the least deprived areas. These data highlight the need for new strategies to address inequalities in cervical screening uptake and can inform further mathematical modelling work to clarify the impact of the HPV vaccination programme on future cervical cancer incidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.